CRISPR could end sickle cell disease, but signing up black patients for clinical trials will be a hard sell – STAT
STAT |
CRISPR could end sickle cell disease, but signing up black patients for clinical trials will be a hard sell
STAT Clinical trials of sickle cell treatments that use CRISPR 5 could start as soon as this year, and some scientists leading those efforts are beginning to lay the groundwork. They are meeting with leaders of black churches and creating teaching guides … |
